![Kristian Rantala](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Kristian Rantala first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 21 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kristian Rantala via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
FRESENIUS SE & CO. KGAA | Medical Specialties | Corporate Officer/Principal | |
Boehringer Ingelheim GmbH
![]() Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder General Counsel Corporate Officer/Principal | |
Zeneus Pharma Ltd.
![]() Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK. | Medical Distributors | Comptroller/Controller/Auditor | |
EUSA Pharma, Inc.
![]() EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director of Finance/CFO | |
FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Biotie Therapies AG
![]() Biotie Therapies AG Pharmaceuticals: MajorHealth Technology Part of Acorda Therapeutics, Inc., Biotie Therapies AG is a holding company that focuses on developing drugs for the treatment of psychiatry and neurology diseases. The company is based in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BEIERSDORF | Household/Personal Care | Corporate Officer/Principal | |
UCB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
ALLIANCE PHARMA PLC | Pharmaceuticals: Major | Chairman | |
University of Oxford | College/University | Doctorate Degree Graduate Degree | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
New York Biotechnology Association, Inc.
![]() New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
ATHERSYS, INC. | Biotechnology | Chairman Chairman | |
Okairos AG
![]() Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Bird Rock Bio, Inc.
![]() Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Chairman | |
Corden Pharma SpA
![]() Corden Pharma SpA Pharmaceuticals: MajorHealth Technology Corden Pharma SpA manufactures sterile liquid dosage forms for injectable use. It offers sterile emulsion technology, pre-filled syringes, distribution of clinical trial medication, and formulation development. The company is headquartered in Caponago, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
Okairos SRL
![]() Okairos SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Okairos SRL is an Italian company that manufactures drugs. The company is based in Rome, Italy. | Pharmaceuticals: Major | Chairman Director/Board Member | |
EUSA Pharma SAS
![]() EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Biotechnology | President | |
Jazz Pharmaceuticals UK Ltd.
![]() Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
Corden Pharma GmbH
![]() Corden Pharma GmbH Pharmaceuticals: MajorHealth Technology Corden Pharma GmbH engages in the development, production, testing, storage, packaging, and distribution of pharmaceutical products. The company was founded on April 14, 2010 and is headquartered in Plankstadt, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Astex Pharmaceuticals, Inc.
![]() Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Laurantis Pharma Oy
![]() Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Versant EuroVentures | Chairman Chief Executive Officer | ||
VIVEVE MEDICAL, INC. | Medical Specialties | Director/Board Member | |
5AM Partners V LLC | Corporate Officer/Principal | ||
Acorda Therapeutics Ltd.
![]() Acorda Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Acorda Therapeutics Ltd. operates as a biopharmaceutical company. It manufactures pharmaceutical preparations and performs research and experimental development. The company was incorporated on March 03, 2009 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer President | |
Camp4 Therapeutics Corp.
![]() Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Jazz Pharmaceuticals France Holdings SAS
![]() Jazz Pharmaceuticals France Holdings SAS Financial ConglomeratesFinance Jazz Pharmaceuticals France Holdings SAS is a biopharmaceutical company that develops medicines. The company is headquartered in Lyon, France. | Financial Conglomerates | Corporate Officer/Principal | |
5AM Opportunities I GP LLC | Corporate Officer/Principal | ||
GABA Therapeutics, Inc.
![]() GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Director/Board Member | |
5am Partners Vi LLC | Corporate Officer/Principal | ||
Presidio Terrace | Director/Board Member | ||
PEAR THERAPEUTICS, INC. | Medical Specialties | Director/Board Member | |
ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Sellas Life Sciences Group Ltd.
![]() Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chairman |
Statistics
International
United States | 23 |
United Kingdom | 8 |
Switzerland | 7 |
Germany | 7 |
Italy | 3 |
Sectoral
Health Technology | 37 |
Consumer Services | 5 |
Finance | 3 |
Distribution Services | 2 |
Consumer Non-Durables | 2 |
Operational
Director/Board Member | 199 |
Corporate Officer/Principal | 65 |
Chairman | 64 |
Independent Dir/Board Member | 51 |
Chief Executive Officer | 25 |
Most connected contacts
Insiders | |
---|---|
Andrew Schwab | 45 |
Bradley Bolzon | 41 |
Mahendra Shah | 34 |
William Burns | 27 |
Ismail Kola | 26 |
James Shannon | 23 |
Guido Magni | 23 |
Peter John Fellner | 21 |
Thomas Taapken | 16 |
Don Bailey | 15 |
Jane Wasman | 14 |
Riku Heikki Rautsola | 12 |
Timo Ilari Veromaa | 12 |
David John Cook | 11 |
Ronald Cohen | 11 |
- Stock Market
- Insiders
- Kristian Rantala
- Company connections